MedTrace Logo

Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients

NCT00345384 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2016-02-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety, efficacy, hemodynamic and respiratory stability of a low-dose of dexmedetomidine infusion in post-operative surgical in-patients undergoing thoracic surgery after discharge from PACU or ICU.

Conditions

  • Post-operative Pain
  • Respiratory Depression

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine titrated over 24 hours

OTHER

Placebo (Normal Saline)

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Michael Ramsay, MD, MD · Baylor Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00345384 on ClinicalTrials.gov